| Theresa F Nielsen, FNP | |
|
2960 Tongass Ave, Ketchikan, AK 99901-5742 | |
| (907) 228-4900 | |
| (800) 852-3264 |
| Full Name | Theresa F Nielsen |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 30 Years |
| Location | 2960 Tongass Ave, Ketchikan, Alaska |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1851462717 | NPI | - | NPPES |
| 1851462717 | Medicaid | VA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | AP128179 (Texas) | Primary |
| 363LF0000X | Nurse Practitioner - Family | 6696 (Connecticut) | Secondary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| South Plains Rural Health Services Inc | 4880505726 | 11 |
News Archive
Novartis today announced it has entered into a clinical research collaboration in which Bristol-Myers Squibb will investigate the safety, tolerability, and efficacy of Mekinist (trametinib) in combination with Opdivo (nivolumab) and Opdivo + Yervoy (ipilimumab) regimen as a potential treatment option for metastatic colorectal cancer in patients with microsatellite stable tumors where the tumors are proficient in mismatch repair (MSS mCRC pMMR).
Menopause marks the end of a woman's reproductive years, which normally occurs in their 50s. The time at which a woman undergoes menopause may indicate future health status, with those having premature menopause at a higher risk of developing multiple and chronic health problems, a new study found.
Chest pain patients educated about their future heart attack risk and involved in deciding care options were more likely than less-aware patients to opt out of stress testing, according to research in Circulation: Cardiovascular Quality and Outcomes, an American Heart Association journal.
For Mazhar Adli, the little glowing dots dancing about on the computer screen are nothing less than the fulfillment of a dream. Those fluorescent dots, moving in real time, are set to illuminate our understanding of the human genome, cancer and other genetic diseases in a way never before possible.
A large study from Children's Hospital Boston and the Boston-based Autism Consortium finds that a genetic test that samples the entire genome, known as chromosomal microarray analysis, has about three times the detection rate for genetic changes related to autism spectrum disorders (ASDs) than standard tests. Publishing in the April issue of Pediatrics (and online March 15), the authors urge that CMA become part of the first-line genetic work-up for ASDs.
› Verified 9 days ago
| Entity Name | Open Door Community Health Centers |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497840656 PECOS PAC ID: 9436067485 Enrollment ID: O20040414000890 |
News Archive
Novartis today announced it has entered into a clinical research collaboration in which Bristol-Myers Squibb will investigate the safety, tolerability, and efficacy of Mekinist (trametinib) in combination with Opdivo (nivolumab) and Opdivo + Yervoy (ipilimumab) regimen as a potential treatment option for metastatic colorectal cancer in patients with microsatellite stable tumors where the tumors are proficient in mismatch repair (MSS mCRC pMMR).
Menopause marks the end of a woman's reproductive years, which normally occurs in their 50s. The time at which a woman undergoes menopause may indicate future health status, with those having premature menopause at a higher risk of developing multiple and chronic health problems, a new study found.
Chest pain patients educated about their future heart attack risk and involved in deciding care options were more likely than less-aware patients to opt out of stress testing, according to research in Circulation: Cardiovascular Quality and Outcomes, an American Heart Association journal.
For Mazhar Adli, the little glowing dots dancing about on the computer screen are nothing less than the fulfillment of a dream. Those fluorescent dots, moving in real time, are set to illuminate our understanding of the human genome, cancer and other genetic diseases in a way never before possible.
A large study from Children's Hospital Boston and the Boston-based Autism Consortium finds that a genetic test that samples the entire genome, known as chromosomal microarray analysis, has about three times the detection rate for genetic changes related to autism spectrum disorders (ASDs) than standard tests. Publishing in the April issue of Pediatrics (and online March 15), the authors urge that CMA become part of the first-line genetic work-up for ASDs.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Theresa F Nielsen, FNP 2960 Tongass Ave, Ketchikan, AK 99901-5742 Ph: (907) 228-4900 | Theresa F Nielsen, FNP 2960 Tongass Ave, Ketchikan, AK 99901-5742 Ph: (907) 228-4900 |
News Archive
Novartis today announced it has entered into a clinical research collaboration in which Bristol-Myers Squibb will investigate the safety, tolerability, and efficacy of Mekinist (trametinib) in combination with Opdivo (nivolumab) and Opdivo + Yervoy (ipilimumab) regimen as a potential treatment option for metastatic colorectal cancer in patients with microsatellite stable tumors where the tumors are proficient in mismatch repair (MSS mCRC pMMR).
Menopause marks the end of a woman's reproductive years, which normally occurs in their 50s. The time at which a woman undergoes menopause may indicate future health status, with those having premature menopause at a higher risk of developing multiple and chronic health problems, a new study found.
Chest pain patients educated about their future heart attack risk and involved in deciding care options were more likely than less-aware patients to opt out of stress testing, according to research in Circulation: Cardiovascular Quality and Outcomes, an American Heart Association journal.
For Mazhar Adli, the little glowing dots dancing about on the computer screen are nothing less than the fulfillment of a dream. Those fluorescent dots, moving in real time, are set to illuminate our understanding of the human genome, cancer and other genetic diseases in a way never before possible.
A large study from Children's Hospital Boston and the Boston-based Autism Consortium finds that a genetic test that samples the entire genome, known as chromosomal microarray analysis, has about three times the detection rate for genetic changes related to autism spectrum disorders (ASDs) than standard tests. Publishing in the April issue of Pediatrics (and online March 15), the authors urge that CMA become part of the first-line genetic work-up for ASDs.
› Verified 9 days ago
Jessica Rae Pilcher, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 3524 Tongass Ave, Ketchikan, AK 99901 Phone: 907-225-9830 | |
Mary Beth Patterson, APRN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 74 Carltons Dr, Ketchikan, AK 99901 Phone: 520-981-3725 | |
Shawna Strouth-shaw, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 320 Bawden St Apt 313, Ketchikan, AK 99901 Phone: 907-220-9982 | |
Tammy Lorraine Earnest, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 120 Carlanna Lake Rd, Ste 102, Ketchikan, AK 99901 Phone: 907-247-9355 Fax: 907-225-9376 | |
Maureen Northway, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 5534 North Tongass Highway, Ketchikan, AK 99901 Phone: 907-225-4325 Fax: 907-531-7369 | |
Amanda E Hulstine, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 3528 Tongass Ave, Ketchikan, AK 99901 Phone: 907-220-4447 | |
Ms. Leslie Amanda Locklear, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 3100 Tongass Ave, Ketchikan, AK 99901 Phone: 907-228-8140 Fax: 907-228-8440 |